Edition:
India

Brainsway Ltd (BWAY.OQ)

BWAY.OQ on NASDAQ Stock Exchange Global Market

8.90USD
21 Oct 2019
Change (% chg)

$0.14 (+1.60%)
Prev Close
$8.76
Open
$8.90
Day's High
$8.90
Day's Low
$8.90
Volume
100
Avg. Vol
3,289
52-wk High
$12.38
52-wk Low
$8.31

Summary

Name Age Since Current Position

David Zacut

67 2019 Chairman of the Board, Interim Chief Executive Officer

Avner Hagai

59 2006 Co-Chairman of the Board

Hadar Levy

2019 Chief Financial Officer, Chief Operating Officer

Yiftach Roth

49 2018 Chief Scientific Officer

Ronen Segal

43 2015 Vice President - Research & Development

Hila Rubinshtein

34 2007 Managing Director of Quality Control

Rami Itselev

38 2015 Internal Auditor

Amit Jino

32 2008 Clinical Experiment Coordinator

Daniel Azriel

66 2006 Director

Yosef Ben Shalom

62 2018 Director

Uri Elmaliach

66 2006 Director

Gavriel Magen

55 2006 Director

Karen Sarid

67 2017 Director

Orly Uri

60 2018 Director

Abraham Zangen

2019 Director

Ety Mitrany Rayten

46 2016 External Director

Biographies

Name Description

David Zacut

Dr. David Zacut serves as Chairman of the Board, Interim Chief Executive Officer at Brainsway Ltd. Previously, he worked as a Doctor at the Hadasah Ein Kerem hospital in Jerusalem. Mr. Zacut holds a Doctorate of Medicine degree from The Hebrew University of Jerusalem.

Avner Hagai

Mr. Avner Hagai serves as Co-Chairman of the Board at Brainsway Ltd since November 7, 2006. Previously, he served as Chief Executive Officer at A.A. Glass Ltd. He also serves as Director at A. Haomer Ltd, A.H. Modi'in Ltd, Siv Real Estate Ltd and Hofit Kibbutz Kinneret Ltd.

Hadar Levy

Mr. Hadar Levy is Chief Financial Officer, Chief Operating Officer of the Company. Mr. Levy has over 15 years of experience in finance and administration. Prior to joining BrainsWay, Mr. Levy served as a finance manager in the Latin America Division at Amdocs Ltd., where he was responsible for accounting, financial reporting, treasury, portfolio management and finance support for Mergers & Acquisitions. Prior to Amdocs, he served as Chief Financial Officer & Business Development of Notal Vision, a healthcare company that researches and develops medical technologies for detecting retinal malfunction and deterioration, where he was responsible for all financial functions, and lead financial rounds of equity including M&A activities with strategic partners. Prior to this position, he served as Controller of GE Healthcare Israel. Mr. Levy began his career at Deloitte LLP, holds a BA in Accounting and Economics and an LLM degree from Bar Ilan University and is a Certified Public Accountant.

Yiftach Roth

Dr. Yiftach Roth serves as Chief Scientific Officer at Brainsway Ltd since November 7, 2006. His work experience includes the following roles: Director at the Company (November 7, 2006-December 19, 2018), Director at Brainsway Inc and Medical Researcher at the Tel Hashomer Medical Technology Institute, Israel. Dr. Roth holds a Bachelor of Science degree, a Master of Science degree and a Doctorate of Science degree, all from the Tel Aviv University, in association with Tel Hashomer Hospital.

Ronen Segal

Mr. Ronen Segal has been appointed Vice President - Research & Development at Brainsway Ltd. effective November 8, 2015. Prior to this role, he served as Deputy Chief Executive Officer at the Company (from April 9, 2014) and as Chief Technology Officer at the Company (from February 27, 2011). His work experience includes the role of Chief Executive Officer at Wietec Ltd. Mr. Segal holds a Bachelors degree in Electronics Engineering from the Jerusalem College of Technology – Machon Lev.

Hila Rubinshtein

Ms. Hila Rubinshtein serves as Managing Director of Quality Control at Brainsway Ltd since October, 2007. Previously, she served as Quality Control Manager at American Medical Laboratories Ltd. Ms. Rubinshtein holds a BSC degree in Life Sciences from the Bar Ilan University.

Rami Itselev

Mr. Rami Itselev has been appointed Internal Auditor at Brainsway Ltd effective July 1, 2015. He serves as Founder and Partner at ERA since 2008. He holds a Bachelors degree in Statistics, a Bachelor of Science degree in Computer Science and a MBA degree, all from Bar Ilan University.

Amit Jino

Mr. Amit Jine serves as Clinical Experiment Coordinator at Brainsway Ltd since November, 2008. Previously, he served as Head of Clinical Experiements at Moach Research Services Ltd. Ms. Jino holds a BSC degree in Humanities from the Bar Ilan University.

Daniel Azriel

Mr. Daniel Azriel serves as Director at Brainsway Ltd since December 20, 2006. Mr. Azriel holds a LLB degree from The Hebrew University of Jerusalem.

Yosef Ben Shalom

Mr. Yosef (Yossi) Ben Shalom has been appointed Director at Brainsway Ltd effective December 19, 2018. His work experience includes the following roles: Founder and Managing Partner of DBSI Investments Ltd (a private equity firm), Chairman of the Board at Shagrir Group Vehicle Services Ltd, Director at a variety of public and private companies and active individual in various registered charities. He holds a Bachelors degree in Economics and a MBA degree, both from Tel Aviv University.

Uri Elmaliach

Dr. Uri Elmaliach serves as Director at Brainsway Ltd since December 20, 2006. He is a member of the Company's Audit Committee. Previously, he worked at Rad Biomed Accelerator Ltd. Mr. Elmaliach holds a Doctorate of Medicine degree in Medicine from The Hebrew University of Jerusalem.

Gavriel Magen

Mr. Gavriel Magen serves as Director at Brainsway Ltd since December 20, 2006. He is a member of the Company's Audit and Finance committees. Mr. Magen holds a Bachelors degree in Business Management from the Rupin College.

Karen Sarid

Ms. Karen Sarid has been appointed Director at Brainsway Ltd effective December 3, 2017. Ms. Sarid holds a Bachelors degree in Accounting and Economics from Haifa University. She is a Certified Chartered Accountant.

Orly Uri

Ms. Orly Uri has been appointed Director at Brainsway Ltd effective December 19, 2018. Her work experience includes the following roles: External Director at the Company (December 20, 2006-April 27, 2016) and Consultant. Ms. Uri holds a Bachelors degree in Economics and a Masters degree in Industrial Engineering and Management Sciences-Medical Management, both from Ben Gurion University.

Abraham Zangen

Prof. Abraham Zangen, Ph.D. is Director of the Company. Professor Zangen is the Head of the Brain Stimulation and Behavior Lab and the Chair of the PsychoBiology Brain Program at Ben-Gurion University in Israel. His research is directed at identifying and understanding altered neuroplasticity in psychiatric disorders, primarily depression, addiction and ADHD, utilizing brain stimulation and imaging techniques to explore mechanisms and potential clinical applications. He co-developed, along with Dr. Yiftach Roth, the Deep TMS coil which serves as Brainsway's platform technology. Professor Zangen has published over 150 peer reviewed articles, reviews and book chapters. He has been awarded numerous prizes for his scientific achievements, including the Medical Futures Innovation Award in London, the Sieratzki Prize for Advances in Neuroscience and the Juludan Prize at the Technion. He has also received several distinguished research grants, including from the National Institutes of Health, H2020 and the Israel Science Foundation.

Ety Mitrany Rayten

Ms. Ety Michal Mitrany Rayten has been appointed External Director at Brainsway Ltd effective June 5, 2016. Her work experience includes the following roles: Chief Economist at Teva-Pharmaceutical Industries Ltd. (from September 2012) and Chief Financial Officer at Global Branded Products (2007-2012). She holds a Bachelors degree in Economics and a Masters degree in Finance and Marketing from Tel Aviv University.